https://www.selleckchem.com/products/azd6738.html
90; CI 95%, 1.62-21.5, and serum potassium ≤3.5mmol/L during hospitalization (OR, 4.97; CI 95%, 1.51-16.36). The Tisdale Score is not a useful tool to stratify hospitalized non-critical COVID-19 patients based on their risks of developing QT interval prolongation. Clinicians should initiate continuous cardiac monitoring for patients who present with a history of ESRD, QTc ≥450ms on admission or serum potassium ≤3.5mmol/L. The Tisdale Score is not a useful tool to stratify hospitalized non-critical COVID-19 patients based on their risk